Resume-aware faculty matching

Find professors who actually fit you

Upload your resume. Four AI agents analyze your background, rank the faculty who fit, inspect their recent research, and help you draft outreach — grounded in their actual work, not templates.

Free to startNo credit cardCancel anytime
Top matches Balanced preset
Dr. Sarah Chen
Stanford · Interpretability · NLP
91
Dr. Marcus Holloway
MIT · Robotics · RL
84
Dr. Aisha Okonkwo
CMU · Fairness · HCI
82
Nova · Professor Researcher · re-ranking top 20…
Thomas Gethin-Jones

Thomas Gethin-Jones

· Assistant Professor (Clinical)

University of Utah · Psychiatry

Active 1949–2022

h-index2
Citations6
Papers52 last 5y
Funding
See your match with Thomas Gethin-Jones — sign in to PhdFit.Sign in

About

Thomas Gethin-Jones, MD, is an Assistant Professor (Clinical) in the Department of Psychiatry at the University of Utah. He earned his medical degree at Drexel University in Philadelphia, PA, and completed his general psychiatry residency at the University of Utah School of Medicine and Affiliated Hospitals, serving as chief resident in his final year of residency. His clinical and academic interests include resident and medical student education and advocacy, inpatient psychiatry, consultation-liaison psychiatry, emergency psychiatry, and patient, staff, and faculty safety. Dr. Gethin-Jones is board-certified in Psychiatry by the American Board of Psychiatry & Neurology and is involved in clinical work as an attending on the Adult Inpatient Psychiatry service at the University of Utah Huntsman Mental Health Institute and on the Inpatient Consultation-Liaison Psychiatry service at University of Utah University Hospital.

Research topics

  • Political Science
  • Medicine
  • Medical education
  • Psychology
  • Psychiatry
  • Nursing
  • Family medicine
  • Clinical psychology
  • Virology

Selected publications

  • Reintervention and Survival After Transcatheter Pulmonary Valve Replacement

    Journal of the American College of Cardiology · 2022 · 65 citations

    • Medicine
    • Surgery
    • Internal medicine
  • Response of US psychiatric programs to the COVID-19 pandemic and the impact on trainees

    BMC Medical Education · 2022 · 5 citations

    • Political Science
    • Medical education
    • Psychology

    BACKGROUND: Medical training program and hospital response to the COVID-19 pandemic has varied greatly and has impacted trainee well-being. Which factors have specifically related to trainee wellness, however, has not yet been examined in depth. The aim of the study was to understand trainee perspectives on the individual psychiatry trainee programs' hospitals' objective COVID-19 preparedness management. We also sought and to gauge how program changes, and general pandemic-related concerns, have been associated with trainee satisfaction and burnout. METHODS: A cross-sectional survey study of psychiatric trainees was distributed electronically throughout the country via various psychiatry residency program listservs in April 2020. Statistical analyses were performed utilizing simple linear regression. RESULTS: From 352 respondents (346 complete responses and 6 partial responses), the most frequent program changes were "decreased number of rotations requiring in-person patient care" and "increased call hours or duties." Of pandemic-related concerns surveyed, the two greatest were "spreading COVID-19 to family/friends" and "co-residents' burnout and anxiety." A positive relationship was found between trainee satisfaction with perceived COVID-19 departmental response and comfort level of residents/fellows in expressing concerns with attending clinicians and department leadership. CONCLUSIONS: Since the start of the COVID-19 pandemic, trainees have experienced a variety of changes to trainee program policies and guidelines. Overall, poor communication and trainee dissatisfaction with departmental response correlated with concern of infection and anxiety/burnout. Insights garnered from this study could provide scaffolding for the best practices to reduce trainee physician anxiety/burnout for the current and future pandemics of this variety and magnitude.

  • Response of US Psychiatric Programs to the COVID-19 Pandemic and the Impact on Trainees

    Research Square (Research Square) · 2021

    • Political Science
    • Medicine
    • Family medicine

    Abstract Background: Medical training program and hospital response to the COVID-19 pandemic has varied greatly and has impacted trainee well-being. Which factors have specifically affected trainee wellness, however, has not yet been examined in depth. The aim of the study was to understand trainee perspectives on the individual psychiatry trainee programs’ hospitals’ objective COVID-19 preparedness management, and to gauge how program changes, and general pandemic-related concerns, have impacted trainee satisfaction and burnout. Methods: A cross-sectional survey study of psychiatric trainees was distributed electronically throughout the country via various psychiatry residency program listservs in April 2020. Statistical analyses were performed utilizing simple linear regression. Results: From 352 respondents, the most frequent program changes were “decreased number of rotations requiring in-person patient care” and “increased call hours or duties.” Of pandemic-related concerns surveyed, the two greatest were “spreading COVID-19 to family/friends” and “co-residents’ burnout and anxiety.” A relationship was found between trainee satisfaction with perceived COVID-19 departmental response and comfort level of residents/fellows in expressing concerns with attending clinicians and department leadership. Conclusions: Since the start of the COVID-19 pandemic, trainees have experienced a variety of changes to trainee program policies and guidelines. Overall, poor communication and trainee dissatisfaction with departmental response correlated with concern of infection and anxiety/burnout. Insights garnered from this study could provide scaffolding for the best practices to reduce trainee physician anxiety/burnout for the current and future pandemics of this variety and magnitude. Trial registration: Not applicable

  • Multicenter Study of Endocarditis After Transcatheter Pulmonary Valve Replacement

    Journal of the American College of Cardiology · 2021 · 96 citations

    • Medicine
    • Internal medicine
    • Surgery
  • Amplatzer Piccolo Occluder clinical trial for percutaneous closure of the patent ductus arteriosus in patients ≥700 grams

    Catheterization and Cardiovascular Interventions · 2020 · 165 citations

    • Medicine
    • Surgery
    • Cardiology

    OBJECTIVES: Characterize the safety and effectiveness of the Amplatzer Piccolo Occluder for patent ductus arteriosus (PDA) closure. BACKGROUND: The presence of a hemodynamically significant PDA has been associated with an increased risk of morbidity and mortality in children born premature. METHODS: This was a single arm, prospective, multicenter, non-randomized study to evaluate the Amplatzer Piccolo Occluder to treat PDA in patients ≥700 g. From June 2017 to February 2019, 200 patients were enrolled at nine centers, with 100 patients weighing ≤2 kg. Primary effectiveness endpoint was the rate of PDA closure at 6-month follow-up. Primary safety endpoint was the rate of major complications through 6 months. Secondary endpoint was rate of significant pulmonary or aortic obstruction through 6 months' follow-up. RESULTS: The implant success rate was 95.5% (191/200) overall and 99% in patients ≤2 kg (99/100). The primary effectiveness endpoint was achieved in 99.4% of implanted patients. Four patients experienced a primary safety endpoint event (2 transfusions, 1 hemolysis, and 1 aortic obstruction). There were no branch pulmonary artery obstructions. Five patients, all ≤2 kg, were noted to have worsening of tricuspid regurgitation (TR) after the procedure. None of the TR incidences manifested clinically. The Amplatzer Piccolo Occluder received FDA approval in January 2019 and became the first device approved for PDA closure in patients ≥700 g. CONCLUSIONS: This study supports the safety and effectiveness of the Amplatzer Piccolo Occluder, particularly in patients between 700 g and 2 kg where there is currently a significant unmet need in the United States. ClinicalTrials.gov identifier: NCT03055858.

Frequent coauthors

  • Brett E. Fenster

    Kaiser Permanente

    6 shared
  • Alex Honeyman

    National Jewish Health

    6 shared
  • Joyce Schroeder

    University of Utah Hospital

    6 shared
  • Barry Make

    National Jewish Health

    6 shared
  • Samuel Lee

    4 shared
  • Russell P. Bowler

    University of Colorado Denver

    4 shared
  • J. Kern Buckner

    National Jewish Health

    4 shared
  • Tyler Durns

    Huntsman Cancer Institute

    2 shared

Similar researchers at University of Utah

  • Resume-aware match score
  • Save to shortlist
  • AI-drafted outreach

See your match with Thomas Gethin-Jones

PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.

  • Free to start
  • No credit card
  • 30-second signup